Skip to main content

Table 1 Characteristics of the sample population

From: Worse pulmonary function in association with cumulative exposure to nanomaterials. Hints of a mediation effect via pulmonary inflammation

Variables

Estimate, (n (%))

Participants

136 (100%)

Age (years, mean (sd))

38.8 (10.2)

Sex

 

Women

41 (30.2%)

Men

95 (69.8%)

BMI (mean (sd))

24.7 (3.9)

Missing data for BMI

8 (6%)

Ethnicity

 

Caucasian

128 (94.1%)

Others

8 (5.9%)

Lifelong tobacco smoking (pack-years) (mean (sd))

4.1 (9.5)

Missing data for lifelong tobacco smoking

6 (4.4%)

Lifestyle

 

Active

77 (56.6%)

Inactive

59 (43.4%)

Employment duration (years, mean (sd))

6.7 (7.6)

10-year cumulative exposure to nanomaterials

 

Particle number concentration (particles/cm3-yrs, median (IQR))

161,692 (462,168)

LDSA (µm2/cm3-yrs, median (IQR))

305 (550)

Pulmonary function and respiratory health

 

FEV1 < LLN

15 (11.6%)

FVC < LLN

8 (6.2%)

FEV1/FVC < LLN

10 (7.8%)

FEF25 − 75% < LLN

10 (7.8%)

Missing data for all pulmonary function parameters

7 (5.1%)

Asthmatics

12 (8.8%)

COPD cases

1 (2.4%)

Inflammatory biomarkers measured in EBC (pre-post shift average)

 

IL-10 (pg/mL, mean (sd))

1.88 (0.63)

IL-1β (pg/mL, mean (sd))

0.51 (0.20)

TNF-α (pg/mL, mean (sd))

0.19 (0.09)

IL-10/TNF-α mean (sd)

11.7 (5.4)

Missing data for all inflammatory biomarkers

7 (5.1%)

  1. BMI: Body Mass Index, IQR: interquartile range LDSA: Lung-Deposited Surface Area, LLN: Lower Limit of Normal, i.e. respiratory parameters expressed as below and above the fifth percentile (or a z-score < − 1.64) of the Global Lung Initiative spirometric reference equations distribution (Quanjer, 2012), FEV1: Forced Expiratory Volume in 1 s, FVC: Forced Vital Capacity, FEF25 − 75%: Forced Expiratory Fluxes at 25% and 75% of FVC, COPD: Chronic obstructive pulmonary disease; EBC: Exhaled Breath Condensate; IL: interleukin; TNF: Tumor Necrosis Factor, sd: standard deviation